Original site: www.cdc.gov/mmwr/preview/mmwrhtml/00021516.htm | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.

[More]
About Us Report Bug

RestoredCDC.org Comparison

Comparison timestamp: 2025-05-03 05:37:40 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/mmwr/preview/mmwrhtml/00021516.htm
Live cdc.gov URL ↗: https://www.cdc.gov/mmwr/preview/mmwrhtml/00021516.htm
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected: Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/mmwr/preview/mmwrhtml/00021516.htm | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
[More]
About Us Report Bug Compare Content
Weekly
September 10, 1993 / 42(35);686
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Diagnosis of Tuberculosis by Nucleic Acid Amplification Methods Applied to Clinical Specimens
CDC and the Food and Drug Administration (FDA) have received inquiries from health-care providers about rapid assays for detecting Mycobacterium tuberculosis in clinical specimens. These assays, currently being offered by several commercial diagnostic laboratories, are based on DNA or RNA amplification procedures, such as the polymerase chain reaction. The false-positive rate, false-negative rate, reproducibility, and predictive value of these tests are not fully understood. In addition, none of the tests have been reviewed or approved by FDA, and their usefulness in patient management and public health practices has not been established. For the diagnostic evaluation of persons suspected of having tuberculosis, the Public Health Service advises clinicians to continue to rely on established techniques: medical history, physical examination, chest roentgenogram, tuberculin skin test, acid-fast stains of clinical specimens, standard or radiometric procedures for cultures and antimicrobial susceptibility testing, and nucleic acid probes for species identification of M. tuberculosis isolates.
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.
Page converted: 09/19/98
HOME | ABOUT MMWR | MMWR SEARCH | DOWNLOADS | RSS | CONTACT
POLICY | DISCLAIMER | ACCESSIBILITY
Department of Health
Morbidity and Mortality Weekly Report and Human Services
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A
This page last reviewed 5/2/01
Note: Comparison ignores leading/trailing whitespace and certain script/tracking codes. Word-level highlighting (optional above) only applies to changed lines.